Home500257 • BOM
add
Lupin Ltd
Previous close
₹2,006.30
Day range
₹1,987.50 - ₹2,020.80
Year range
₹1,200.35 - ₹2,312.00
Market cap
958.92B INR
Avg Volume
27.12K
P/E ratio
34.83
Dividend yield
0.40%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 56.73B | 12.59% |
Operating expense | 28.73B | 7.98% |
Net income | 8.53B | 74.12% |
Net profit margin | 15.03 | 54.63% |
Earnings per share | 18.64 | 73.88% |
EBITDA | 13.62B | 48.62% |
Effective tax rate | 18.52% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.12B | 68.06% |
Total assets | 254.82B | 8.69% |
Total liabilities | 97.62B | -3.69% |
Total equity | 157.20B | — |
Shares outstanding | 455.95M | — |
Price to book | 5.85 | — |
Return on assets | — | — |
Return on capital | 15.22% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 8.53B | 74.12% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis. Wikipedia
Founded
1968
Headquarters
Website
Employees
19,210
